Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases

CMO Selection Criteria

Pascal Bolon
BioProcess International, Vol. 9, No. 7, August 2011, p. 42

(Click to enlarge)

Selecting a CMOis critical to biotech biologic drug development. A key factor for selecting a CMOis experience. How do you measure experience? It can be measured in many ways, metrics include

  • Number of GMP processes developed by the CMO

  • Number of projects involving your strain

  • Number of projects involving your product type

  • GMP production success rate

  • Number of GMP lots produced.

Eurogentec's Biologics Division is specialized in the manufacturing of biopharmaceuticals from microbial sources such as bacteria, yeast, and biosafety level 2 organisms. Eurogentec manufactures in accordance with GMP since 1994.

Host Cell Experience — Microbial Experts

  • Escherichia coli

  • Pichia pastoris

  • Hansenula polymorpha

  • Saccharomyces cerevisiae

  • Numerous BSL-2 organisms.

Chemistry Experience — Conjugation Experts

  • Maleimide

  • Glutaraldehyde

  • Other chemistries available.

Product Family Experience

  • Recombinant proteins

  • Plasmid DNA

  • Protein–PEG conjugations

  • Protein–protein conjugations

  • Protein–peptide conjugations.

GMP Infrastructure

  • Multiproduct facility

  • Separate HVAC systems

  • Three GMP fermentation suites (80 L, 150 L, 500 L)

  • Two GMP purification suites

  • One GMP sterile filtration suite.

Figure 1: (Click to enlarge)

Figure 2: (Click to enlarge)

Figure 3: (Click to enlarge)

Process Development Strategies

  • FastTrack — quick to clinic

  • OptiTrack — robustness built in.

Author Details
Dr. Pascal Bolon is biologics sales and marketing manager at Eurogentec SA, Rue du Bois Saint-Jean 5, 4102 Seraing, Belgium; 32-4-366-6116;

| | Share
The 2014 BioProcess International Awards
Nominations are now open for the 2014 BioProcess International Awards. The 2014 awards recognize and honor the individuals, organizations and technologies that most significantly impacted and advanced biotherapeutic development and manufacturing.

The winners will be announced at our awards ceremony during the BioProcess International Conference & Exhibition in Boston, October 22, 2014.

Submit your nominations today!

Biotherapeutic Formulation and Delivery
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550

In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer.

By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way BioProcess International uses cookies please go to our Cookie Policy page.